BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12767000)

  • 1. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
    Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
    J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population.
    Yoshizawa H; Tanaka J; Miyakawa Y
    Intervirology; 2006; 49(1-2):7-17. PubMed ID: 16166783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM; Wilson ML
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
    Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
    Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long term outcome of thirty eight post-transfusion hepatitis C.
    Punyagupta S; Siwadune T
    J Med Assoc Thai; 2001 Jan; 84(1):12-8. PubMed ID: 11281489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-epidemiology of hepatitis C viral infection in northeastern Thailand.
    Chunlertrith K; Sukeepaisarnjaroen W; Mairiang P; Urwijitaroon Y; Takase K; Yamauchi T; Yoshimura H; Tameda Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):273-6. PubMed ID: 11127325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposure.
    Cecere A; Marotta F; Lucariello A; Tancredi L; Vangieri B; Gattoni A
    Panminerva Med; 2003 Dec; 45(4):253-9. PubMed ID: 15206166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The natural course of hepatitis B and hepatitis C virus infection].
    Schwabe RF; Stremmel W
    Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical picture and evolution of hepatitis C].
    Marcellin P; Erlinger S
    Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
    Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of hepatitis C viral infection.
    Muir AJ
    Semin Gastrointest Dis; 2000 Apr; 11(2):54-61. PubMed ID: 10803630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A national project for the management of viral hepatitis toward prevention of hepatocellular carcinoma in Japan].
    Tanaka J; Yoshizawa H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):864-70. PubMed ID: 15222102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
    Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
    Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.